Pharmacy Times
JUNE 18, 2025
J Am Pharm Assoc (2003). Am J Health Syst Pharm. 2019;76(4):251-253. doi:10.1093/ajhp/zxy040 13. Foster AA, Daly CJ, Logan T, et al. Implementation and evaluation of social determinants of health practice models within community pharmacy. 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005
Pharmacy Times
JUNE 23, 2025
From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In However, 505(b)(2) drugs have been available since the 1980s. “CMS
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
DECEMBER 19, 2024
Antibiotics have long been essential in treating common infections and supporting complex medical interventions like surgeries, cancer chemotherapy, and organ transplants. Between 1935 and 2003, the world saw the introduction of 14 new classes of antibiotics. However, over the last 20 years, new approvals have dwindled significantly.
STAT
SEPTEMBER 22, 2023
Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions. The techs who were queried identified chemotherapies; ADHD medicines; three drugs for weight loss and diabetes — Mounjaro, Ozempic, and Wegovy — and local anesthetics such as lidocaine as the top drugs experiencing shortages.
European Pharmaceutical Review
OCTOBER 19, 2023
How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? There is great hope of this class of drug specifically to work in conjunction with immunotherapeutics, given the lack of toxicity of radiopharmaceuticals in general compared to most chemotherapies.
Pharmaceutical Technology
JULY 23, 2008
” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “And there’s a tremendous opportunity to meet their needs.” ” Global outlook IMS Health predicts that the global market for cancer drugs will grow twice as fast as that of other pharmaceuticals over the next five years.
The Thyroid Pharmacist
SEPTEMBER 1, 2023
They include anesthetics, antacids, anti-anxiety medications, antibiotics, antidepressants, antifungals, cholesterol-lowering medications, anti-malarial medications, chemotherapy, appetite suppressants, arthritis medications, psychotropics, and steroids. 2003 Jun 7;32(20):933; Welsch M, et al. Acta Paediatr. 1995;84(5):555-560.
Expert insights. Personalized for you.
Let's personalize your content